Cancer clinical trials in the region Normandie

89 currently recruiting clinical trials
Region Normandie

Phase 3 Colon cancer Rectal cancer
#NCT04120701
Adenocarcinoma Localized Locally Advanced Systemic Treatment-Naive Surgery Systemic Treatment-Naive Surgery
Chemotherapy Radiotherapy Chemotherapy Radiotherapy
10 main criterias to confirm
Centre François Baclesse (Caen ), CHU Caen Normandie (Caen), Centre Hospitalier de Blois (Blois), Centre Hospitalier Universitaire de Rouen (Rouen), Centre Hospitalier Jacques Monod (Flers) (and 5 more...)
CHU Dijon
Phase 3 Lung cancer
#NCT06472245
NSCLC (Non-Small Cell Lung Cancer) Metastatic Immunotherapy
EGFR ALK ROS-1
6 main criterias to confirm
Centre Hospitalier du Mans (Le Mans)
OSE Immunotherapeutics
Phase 3 Lung cancer
#NCT06430866
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Localized Locally Advanced Surgery Chemotherapy Surgery Chemotherapy
EGFR ALK ROS-1 Immunotherapy Immunotherapy
12 main criterias to confirm
Centre François Baclesse (Caen )
Amgen
Phase 3 Colon cancer Rectal cancer
#NCT05078047
Adenocarcinoma Metastatic MSI/dMMR Immunotherapy
7 main criterias to confirm
Centre François Baclesse (Caen ), Centre Hospitalier Intercommunal Elbeuf - Louviers - Val de Reuil (Saint-Aubin-lès-Elbeuf), Centre Hospitalier Mémorial de Saint-Lô (Saint-Lô)
UNICANCER
Phase 3 Pancreas cancer
#NCT00268411
Adenocarcinoma Metastatic Systemic Treatment-Naive
Chemotherapy Radiotherapy Chemotherapy Radiotherapy
8 main criterias to confirm
Centre Hospitalier Victor Jousselin (Dreux), Centre Hospitalier de Chartres (Le Coudray), Centre Hospitalier du Mans (Le Mans)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 3 Colon cancer Rectal cancer
#NCT05253651
Adenocarcinoma Locally Advanced Metastatic HER2 Systemic Treatment-Naive
KRAS G12C KRAS non G12C NRAS
8 main criterias to confirm
Centre Hospitalier Universitaire de Rouen (Rouen)
Seagen
Phase 3 Lymphoma
#NCT06508658
B cell lymphoma Large B cell lymphoma CD20 None Chemotherapy Targeted therapy
Systemic Treatment-Naive
9 main criterias to confirm
CHU Caen Normandie (Caen)
Genmab
Phase 3 Breast cancer
#NCT03820830
HER2 Negative HR Positive Localized Systemic Treatment-Naive Surgery Radiotherapy
Chemotherapy Targeted therapy
8 main criterias to confirm
Centre François Baclesse (Caen )
ETOP IBCSG Partners Foundation
Phase 3 Lung cancer
#NCT03774732
NSCLC (Non-Small Cell Lung Cancer) Squamous NSCLC Non-squamous NSCLC Locally Advanced Metastatic PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%)
EGFR ALK
8 main criterias to confirm
Centre François Baclesse (Caen ), CHU Caen Normandie (Caen)
UNICANCER
Phase 3 Breast cancer
#NCT06312176
HER2 Negative HR Positive Locally Advanced Metastatic Targeted therapy Hormone therapy
Chemotherapy
8 main criterias to confirm
Centre François Baclesse (Caen )
Merck Sharp & Dohme LLC